Familial gastric cancer: genetic susceptibility, pathology, and implications for management - 30/01/15
Summary |
Familial gastric cancer comprises at least three major syndromes: hereditary diffuse gastric cancer, gastric adenocarcinoma and proximal polyposis of the stomach, and familial intestinal gastric cancer. The risk of development of gastric cancer is high in families affected b-y these syndromes, but only hereditary diffuse gastric cancer is genetically explained (caused by germline alterations of CDH1, which encodes E-cadherin). Gastric cancer is also associated with a range of several cancer-associated syndromes with known genetic causes, such as Lynch, Li-Fraumeni, Peutz-Jeghers, hereditary breast–ovarian cancer syndromes, familial adenomatous polyposis, and juvenile polyposis. We present contemporary knowledge on the genetics, pathogenesis, and clinical features of familial gastric cancer, and discuss research and technological developments, which together are expected to open avenues for new genetic testing approaches and novel therapeutic strategies.
Le texte complet de cet article est disponible en PDF.Plan
Vol 16 - N° 2
P. e60-e70 - février 2015 Retour au numéro
Article précédent
- Panitumumab plus radiotherapy versus chemoradiotherapy in patients with unresected, locally advanced squamous-cell carcinoma of the head and neck (CONCERT-2): a randomised, controlled, open-label phase 2 trial
- Jordi Giralt, Jose Trigo, Sandra Nuyts, Mahmut Ozsahin, Krzysztof Skladowski, Georges Hatoum, Jean-Francois Daisne, Alejandro César Yunes Ancona, Anthony Cmelak, Ricard Mesía, Alicia Zhang, Kelly S Oliner, Ari VanderWalde
- Building a global consensus approach to chordoma: a position paper from the medical and patient community
- Silvia Stacchiotti, Josh Sommer, on behalf of a Chordoma global consensus group †
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?